RxDoctor Payments Data

Ralph Vance, MD

Gastroenterology · Flowood, MSNPI 1487974192

Payments from drug & device makers

$2,967in general payments, 2019–2025

Across 60 payments — averaging $49.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • AbbVie$303
  • Takeda Pharmaceuticals U.S.A., Inc.$191
  • ERBE USA Inc$135
  • Medtronic$133
  • Apollo Endosurgery US Inc$119
  • plus $570 from 15 others
$2,699in research payments, 2019–2025

Across 3 payments — averaging $899.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$3K

What the payments were for

  • Travel & lodging$69023%
  • Food & beverage$2,21275%
  • Education$642%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,967 in reported general payments places this provider in the 40th percentile of 127 gastroenterology providers in Mississippi.

See all gastroenterology providers in Mississippi

Medicare billing

Part B allowed, 2024
$393,425
Medicare patients
698
Services billed
11,807

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase23$28,614
TrulancePlecanatide11$9,131
Sucralfate59$8,198
ClenpiqSod Picosulf/Mag Ox/Citric Ac39$6,349
Lubiprostone20$2,981
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg66$1,901
Pantoprazole Sodium244$1,670
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl73$1,115
Famotidine104$997
Dicyclomine Hcl61$962
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl24$418
Ondansetron OdtOndansetron25$302
Lansoprazole12$153
Amoxicillin12$59

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon$303$28,61423 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$82$9,13111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 127 gastroenterology providers in Mississippi.

Other gastroenterology in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →